Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Chunghwa Telecom
CHT
$32.9B
| $98.5M | 0.13% |
2,796,148
+45,764
| +2% | +$1.6M |
|
177
Blackstone
BX
$110B
| $98M | 0.13% |
2,938,500
+1,139,800
| +63% | +$35.8M |
|
|
XLNX
178
DELISTED
Xilinx Inc
XLNX
| $97.8M | 0.12% |
1,520,605
+1,232,206
| +427% | +$77.8M |
|
179
Cable One
CABO
$192M
| $97.5M | 0.12% |
137,200
+65,847
| +92% | +$45.2M |
|
180
TFS Financial
TFSL
$4.83B
| $97.3M | 0.12% |
6,291,222
+247,100
| +4% | +$3.99M |
|
181
IAMGOLD
IAG
$10.4B
| $97.3M | 0.12% |
18,851,800
+873,700
| +5% | +$3.93M |
|
182
Waters Corp
WAT
$40.7B
| $96.8M | 0.12% |
526,400
+359,000
| +214% | +$62.4M |
|
183
RenaissanceRe
RNR
$13.2B
| $96.3M | 0.12% |
692,497
+318,282
| +85% | +$44.7M |
|
184
McCormick & Company Non-Voting
MKC
$14.2B
| $96.3M | 0.12% |
1,974,200
+415,200
| +27% | +$21M |
|
185
Southwest Airlines
LUV
$22.3B
| $95.2M | 0.12% |
1,531,380
-67,920
| -4% | -$3.95M |
|
186
JB Hunt Transport Services
JBHT
$24.9B
| $94.5M | 0.12% |
1,034,544
+409,200
| +65% | +$36.2M |
|
187
Canadian Pacific Kansas City
CP
$80.8B
| $94.1M | 0.12% |
2,925,000
-1,254,000
| -30% | -$38.9M |
|
|
CLR
188
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $93.5M | 0.12% |
2,892,600
+2,389,400
| +475% | +$94.5M |
|
|
CSGS
189
DELISTED
CSG Systems International
CSGS
| $93.3M | 0.12% |
2,298,475
+117,753
| +5% | +$4.62M |
|
|
HA
190
DELISTED
Hawaiian Holdings, Inc.
HA
| $93.2M | 0.12% |
1,985,100
-396,100
| -17% | -$20.1M |
|
191
Church & Dwight Co
CHD
$24.4B
| $93M | 0.12% |
1,791,900
+1,099,670
| +159% | +$56.2M |
|
192
Cigna
CI
$72.4B
| $92.9M | 0.12% |
555,100
-103,800
| -16% | -$16.7M |
|
193
Healthcare Realty
HR
$6.56B
| $92.9M | 0.12% |
2,985,972
+1,450,372
| +94% | +$45.7M |
|
194
Monster Beverage
MNST
$89.2B
| $92.8M | 0.12% |
7,472,800
+256,000
| +4% | +$3.08M |
|
195
Evercore
EVR
$11.7B
| $92.8M | 0.12% |
1,316,100
+80,100
| +6% | +$5.82M |
|
|
DCM
196
DELISTED
NTT DOCOMO, Inc.
DCM
| $92.7M | 0.12% |
3,920,100
+539,400
| +16% | +$13.1M |
|
197
Coca-Cola
KO
$372B
| $92.7M | 0.12% |
2,066,200
+1,968,100
| +2,006% | +$87M |
|
198
Keurig Dr Pepper
KDP
$39.7B
| $92.7M | 0.12% |
1,016,900
+347,400
| +52% | +$32.5M |
|
199
Netflix
NFLX
$311B
| $92.5M | 0.12% |
6,193,000
-7,165,000
| -54% | -$110M |
|
200
Union Pacific
UNP
$174B
| $92.3M | 0.12% |
+847,500
| New | +$92.4M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.